POMALYST 2 MG CAP DURA CT BL AL PLAS PVC/PCTFE TRANS X 14
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1018004120033 -
GGREM
505122110023402 -
Código de barras
7896016808524
O que a fonte publica
- Detentor do registro
- BRISTOL-MYERS SQUIBB FARMACÊUTICA LTDA
- Princípios ativos
- POMALIDOMIDA
- Embalagem
- 2 MG CAP DURA CT BL AL PLAS PVC/PCTFE TRANS X 14
- Regime de dispensação
- Tarja Vermelha sob restrição
- Tipo de produto
- Novo
- Classe terapêutica
- L1K - ANTINEOPLÁSICOS LIDOMIDA
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "POMALYST 2 MG CAP DURA CT BL AL PLAS PVC/PCTFE TRANS X 14",
"holder": "BRISTOL-MYERS SQUIBB FARMACÊUTICA LTDA",
"stripe": "Tarja Vermelha sob restrição",
"barcodes": [
"7896016808524"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "505122110023402",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "56.998.982/0001-07",
"priceRegime": "Regulado",
"productName": "POMALYST",
"productType": "Novo",
"hospitalOnly": false,
"presentation": "2 MG CAP DURA CT BL AL PLAS PVC/PCTFE TRANS X 14",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha sob restrição",
"factoryPrices": {
"icms-0": "8554.32",
"icms-12": "9720.82",
"icms-17": "10306.41",
"icms-18": "10432.10",
"icms-19": "10560.89",
"icms-20": "10692.90",
"icms-21": "10828.26",
"icms-22": "10967.07",
"icms-23": "11109.50",
"icms-17.5": "10368.87",
"icms-19.5": "10626.48",
"icms-20.5": "10760.15",
"icms-22.5": "11037.84",
"icms-12-alc": "8679.31",
"icms-17-alc": "9202.15",
"icms-18-alc": "9314.37",
"icms-19-alc": "9429.36",
"icms-20-alc": "9547.23",
"icms-21-alc": "9668.08",
"icms-22-alc": "9792.03",
"icms-23-alc": "9919.20",
"withoutTaxes": "7637.78",
"icms-17.5-alc": "9257.92",
"icms-19.5-alc": "9487.93",
"icms-20.5-alc": "9607.27",
"icms-22.5-alc": "9855.20"
},
"pisCofinsList": "Negativa",
"substanceText": "POMALIDOMIDA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "11475.32",
"icms-12": "13040.13",
"icms-17": "13825.68",
"icms-18": "13994.29",
"icms-19": "14167.06",
"icms-20": "14344.14",
"icms-21": "14525.73",
"icms-22": "14711.93",
"icms-23": "14903.00",
"icms-17.5": "13909.47",
"icms-19.5": "14255.04",
"icms-20.5": "14434.36",
"icms-22.5": "14806.87",
"icms-12-alc": "11998.64",
"icms-17-alc": "12721.43",
"icms-18-alc": "12876.57",
"icms-19-alc": "13035.54",
"icms-20-alc": "13198.49",
"icms-21-alc": "13365.55",
"icms-22-alc": "13536.91",
"icms-23-alc": "13712.71",
"withoutTaxes": "10558.79",
"icms-17.5-alc": "12798.53",
"icms-19.5-alc": "13116.51",
"icms-20.5-alc": "13281.49",
"icms-22.5-alc": "13624.24"
},
"invalidBarcodes": [],
"activeSubstances": [
"POMALIDOMIDA"
],
"therapeuticClass": "L1K - ANTINEOPLÁSICOS LIDOMIDA",
"commercialisation": {
"year": 2025,
"marketed": true
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1018004120033",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "L1K",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:505122110023402"